Home  >  Products  >  MAFB (v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)) Blocking Peptide (the N terminal of protein) (100ug)
MAFB (v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)) Blocking Peptide (the N terminal of protein) (100ug)

MAFB (v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MAFB antibody (Catalogue #: ARP58149_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP58149
Size: 100 ug
Weight: 36kDa
Gene: 9935
Format: Lyophilized powder
Target: MAFB is a basic leucine zipper (bZIP) transcription factor that plays an important role in the regulation of lineage-specific hematopoiesis. The nuclear protein represses ETS1-mediated transcription of erythroid-specific genes in myeloid cells. The protein encoded by this gene is a basic leucine zipper (bZIP) transcription factor that plays an important role in the regulation of lineage-specific hematopoiesis. The encoded nuclear protein represses ETS1-mediated transcription of erythroid-specific genes in myeloid cells. This gene contains no introns. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: KRML; MGC43127
See Full Product Listings >